IB Diffusion
Imaging Biometrics
| Product specifications |
Information source:
Vendor
Last updated: July 31, 2020 |
| General | |
|---|---|
| Product name | IB Diffusion |
| Company | Imaging Biometrics |
| Subspeciality | Multiple |
| Modality | MR |
| Disease targeted | Solid tumor |
| Key-features | ADC calculations, parameter normalization |
| Suggested use | |
| Data characteristics | |
| Population | tumors |
| Input | Commonly acquired DWI datasets |
| Input format | DICOM |
| Output | Various parameter maps |
| Output format | DICOM |
| Technology | |
| Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
| Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Hybrid solution |
| Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
| Processing time | < 3 sec |
| Certification | |
|
CE
|
Certified,
Class I
, MDD
|
|
FDA
|
510(k) cleared, Class II |
| Market presence | |
| On market since | 01-2013 |
| Distribution channels | Eureka Clinical AI, QMENTA, Blackford Analysis, Medimsight, CorTechs Labs, aycan Medical Systems, Pixmeo |
| Countries present (clinical, non-research use) | |
| Paying clinical customers (institutes) | |
| Research/test users (institutes) | |
| Pricing | |
| Pricing model | Pay-per-use, Subscription |
| Based on | Number of users, Number of installations, Number of analyses |
| Evidence | |
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers |
|